Efficacy and Safety Study of Gabapentin as add-on to Morphine in Paediatric Patients Affected by Chronic Pain
Status:
Withdrawn
Trial end date:
2019-10-21
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the efficacy of gabapentin as adjunctive therapy to
morphine in the treatment of severe chronic neuropathic or mixed pain in children from 3
months to less than 18 years of age assessed by the difference in average pain scores between
treatment arms at the end of the treatment period.